Orenitram®, Remodulin®, and Tyvaso® and Tyvaso DPI® are registered trademarks of United Therapeutics Corporation. Adcirca® is a registered trademark of Eli Lilly and Company. All other trademarks and registered trademarks are the property of their respective owners.